We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The locations for a Marketing Authorisation Holder (MAH) and a Qualified Person responsible for Pharmacovigilance (QPPV)
This Heat-Health Alert action card summarises the suggested actions that providers of health or social care should consider at each Heat-Health Alert level.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
How to support patients in accessing population screening programmes and obtaining screening results.
The Medicines and Healthcare products Regulatory Agency (MHRA) offer a pre-submission service before applying for medicines Marketing Authorisations.
This page details the Knowledge and Library Services available to UKHSA staff.
Information for parents of babies who carry a gene for unusual haemoglobin.
Screening standards for the NHS bowel cancer screening programme (BCSP).
Data to support providers in improving cervical screening coverage and access to cervical screening services.
Sets out how responsible authorities should ensure continuity of care for adults who receive care and support and move to another country in the UK.
Points to consider when using real-world data in clinical studies
Guide to the services offered by the mycology reference laboratory (MRL) to help medical professionals manage fungal infections.
Guidance on naming human medicines, including Braille requirements for the name on the product label.
A guide to how to use the National Drugs Control System (NDS) for licence applications for the import and export of controlled drugs and precursor chemicals.
A list of all consultants in receipt of a national Clinical Excellence, Clinical Impact or Distinction Award on 1 April 2024.
Resources to support the management of children who missed newborn screening tests.
Information for public health professionals on immunisation.
Advice to inform evidence-based policy making.
Advice for women who are pregnant or considering pregnancy, who are pregnant and diagnosed with Zika, and for women whose baby is possibly affected.
Information on taking, submitting and processing clinical samples from patients suspected of having zoonotic (acquired from birds or mammals) influenza A of any subtype.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).